Autor: "Bouton TC" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Methods for handling missing data in serially sampled sputum specimens for mycobacterial culture conversion calculation.
Autorzy:: Malatesta S; Department of Biostatistics, Boston University School of Public Health, 801 Massachusetts Ave, 3rd Floor, Boston, MA, 02119, USA. .
Weir IR; Center for Biostatistics in AIDS Research in the Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Weber SE; Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
Bouton TC; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Carney T; Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Tygerberg, South Africa.; Department of Psychiatry and Mental Health, University of Cape Town, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
Theron D; Brewelskloof Hospital, Worcester, South Africa.
Myers B; Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Tygerberg, South Africa.; Department of Psychiatry and Mental Health, University of Cape Town, Groote Schuur Hospital, Observatory, Cape Town, South Africa.; Curtin enAble Institute, Faculty of Health Sciences, Curtin University, Perth, Australia.
Horsburgh CR; Department of Biostatistics, Boston University School of Public Health, 801 Massachusetts Ave, 3rd Floor, Boston, MA, 02119, USA.; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Departments of Epidemiology and Global Health, Boston University School of Public Health, Boston, MA, USA.
Warren RM; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and South African Medical Research Council Centre for Tuberculosis Research, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Jacobson KR; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
White LF; Department of Biostatistics, Boston University School of Public Health, 801 Massachusetts Ave, 3rd Floor, Boston, MA, 02119, USA.; Pokaż więcej
Źródło:: BMC medical research methodology [BMC Med Res Methodol] 2022 Nov 19; Vol. 22 (1), pp. 297. Date of Electronic Publication: 2022 Nov 19.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Sputum*
Research Design*
Humans ; Longitudinal Studies ; Data Interpretation, Statistical ; Bias

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study.
Autorzy:: Bouton TC; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
Lodi S; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Turcinovic J; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.
Schaeffer B; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Weber SE; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
Quinn E; Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, Massachusetts, USA.
Korn C; Department of Infection Control, Boston Medical Center, Boston, Massachusetts, USA.
Steiner J; Department of Infection Control, Boston Medical Center, Boston, Massachusetts, USA.
Schechter-Perkins EM; Department of Emergency Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
Duffy E; Department of Pathology and Laboratory Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
Ragan EJ; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
Taylor BP; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Miller N; Department of Pathology and Laboratory Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.
Davidoff R; Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, USA.
Hanage WP; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.
Connor J; National Emerging Infectious Diseases Laboratories, Boston University, Boston, Massachusetts, USA.; Department of Microbiology, Boston University School of Medicine, Boston, Massachusetts, USA.
Pierre C; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Department of Infection Control, Boston Medical Center, Boston, Massachusetts, USA.
Jacobson KR; Section of Infectious Diseases, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2021 Sep 17; Vol. 8 (10), pp. ofab465. Date of Electronic Publication: 2021 Sep 17 (Print Publication: 2021).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals?
Autorzy:: Epstein RL; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Sperring H; Center for Infectious Diseases, Boston Medical Center, Boston, Massachusetts, USA.
Hofman M; Boston Medical Center, Boston, Massachusetts, USA.
Lodi S; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
White LF; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.
Barocas JA; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Bouton TC; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Xiao Y; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Hsu HE; Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts, USA.
Miller NS; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Linas BP; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
Marathe JG; Section of Infectious Diseases, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Open forum infectious diseases [Open Forum Infect Dis] 2021 May 20; Vol. 8 (6), pp. ofab164. Date of Electronic Publication: 2021 May 20 (Print Publication: 2021).
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Autorzy:: Kataria Y; Clinical Chemistry, Department of Pathology and Lab Medicine, Boston Medical Center, 670 Albany St., Boston, MA, 02118, USA. .; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA. .
Cole M; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Duffy E; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
de la Cena K; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.
Schechter-Perkins EM; Department of Emergency Medicine, Boston University School of Medicine/Boston Medical Center, Boston, MA, USA.
Bouton TC; Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
Werler MM; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Pierre C; Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
Ragan EJ; Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
Weber SE; Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
Jacobson KR; Section of Infectious Diseases, Boston Medical Center, Boston, MA, USA.
Andry C; Clinical Chemistry, Department of Pathology and Lab Medicine, Boston Medical Center, 670 Albany St., Boston, MA, 02118, USA.; Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, MA, USA.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 May 06; Vol. 11 (1), pp. 9694. Date of Electronic Publication: 2021 May 06.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Viral/*immunology
COVID-19/*epidemiology
COVID-19/*immunology
Immunoglobulin G/*immunology
SARS-CoV-2/*immunology
Adult ; Antibodies, Viral/blood ; Boston/epidemiology ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19 Testing ; Female ; Health Personnel ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; Risk Factors ; SARS-CoV-2/isolation & purification ; Seroepidemiologic Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Decentralized Care for Rifampin-Resistant Tuberculosis, Western Cape, South Africa.
Autorzy:: Leavitt SV
Jacobson KR
Ragan EJ
Bor J
Hughes J
Bouton TC
Dolby T
Warren RM
Jenkins HE; Pokaż więcej
Źródło:: Emerging infectious diseases [Emerg Infect Dis] 2021; Vol. 27 (3), pp. 728-739.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Tuberculosis*
Tuberculosis, Multidrug-Resistant*
Humans ; Rifampin ; South Africa

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis.
Autorzy:: Bouton TC; Division of Infectious Diseases, Brown University Alpert School of Medicine, Providence, RI, United States of America.
de Vos M; Department of Science and Technology, National Research Foundation Centre of Excellence in Biomedical Tuberculosis Research, South Africa Medical Research Council for Tuberculosis Research, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Ragan EJ; Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, United States of America.
White LF; Department of Biostatistics Boston University School of Public Health, Boston, MA, United States of America.
Van Zyl L; Brewelskloof Hospital, Worcester, South Africa.
Theron D; Brewelskloof Hospital, Worcester, South Africa.
Horsburgh CR; Department of Medicine, Boston University School of Medicine, Boston, MA, United States of America.; Departments of Epidemiology, Biostatistics and Global Health, Boston University School of Public Health, Boston, MA, United States of America.
Warren RM; Department of Science and Technology, National Research Foundation Centre of Excellence in Biomedical Tuberculosis Research, South Africa Medical Research Council for Tuberculosis Research, Cape Town, South Africa.; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Jacobson KR; Section of Infectious Diseases, Boston University School of Medicine, Boston, MA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2019 Oct 17; Vol. 14 (10), pp. e0223308. Date of Electronic Publication: 2019 Oct 17 (Print Publication: 2019).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Substitution*
Antitubercular Agents/*therapeutic use
Diarylquinolines/*therapeutic use
Mycobacterium tuberculosis/*drug effects
Tuberculosis, Multidrug-Resistant/*drug therapy
Tuberculosis, Multidrug-Resistant/*microbiology
Adult ; Coinfection ; Diarylquinolines/administration & dosage ; Drug Therapy, Combination ; Female ; HIV Infections ; Humans ; Male ; Middle Aged ; Retreatment ; Retrospective Studies ; Rifampin/therapeutic use ; South Africa ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/diagnosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Tuberculosis: An Epidemic Perpetuated by Health Inequalities.
Autorzy:: Szkwarko D; Warren Alpert Medical School of Brown University, Providence, RI; University of Massachusetts Medical School, Worcester, MA.
Bouton TC; Warren Alpert Medical School of Brown University, Providence, RI; Boston University, Boston, MA.
Rybak NR; Warren Alpert Medical School of Brown University, Providence, RI.
Carter EJ; Warren Alpert Medical School of Brown University, Providence, RI.
Chiang SS; Warren Alpert Medical School of Brown University, Providence, RI.; Pokaż więcej
Źródło:: Rhode Island medical journal (2013) [R I Med J (2013)] 2019 Sep 03; Vol. 102 (7), pp. 47-50. Date of Electronic Publication: 2019 Sep 03.
Typ publikacji:: Journal Article
MeSH Terms:: Global Health*
Socioeconomic Factors*
Communicable Disease Control/*organization & administration
Epidemics/*prevention & control
Health Services Accessibility/*organization & administration
Tuberculosis/*prevention & control
Adolescent ; Adult ; Child ; Goals ; Health Services Research ; Health Status Disparities ; Humans ; Tuberculosis/epidemiology ; World Health Organization

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: High Rates of Indeterminate TB Tests Among Hospitalized Patients: Can We Optimize Use of Gamma Interferon Release Assays in Tuberculosis?
Autorzy:: Bouton TC; Division of Infectious Diseases, Warren Alpert Medical School of Brown University, Providence, RI.
Gillani FS; Division of Infectious Diseases, Warren Alpert Medical School of Brown University; The Miriam Hospital, Immunology Center, Providence, RI.
Lu S; Department of Pathology and Laboratory Medicine, Warren Alpert Medical School of Brown University, Providence, RI.
Carter EJ; Division of Pulmonary, Critical Care and Sleep Medicine, Warren Alpert Medical School of Brown University, Providence, RI.; Pokaż więcej
Źródło:: Rhode Island medical journal (2013) [R I Med J (2013)] 2019 Aug 01; Vol. 102 (6), pp. 27-30. Date of Electronic Publication: 2019 Aug 01.
Typ publikacji:: Journal Article
MeSH Terms:: Immunocompromised Host*
Interferon-gamma Release Tests/*statistics & numerical data
Mass Screening/*methods
Tuberculosis/*diagnosis
Adult ; Aged ; Female ; Hospitalization ; Humans ; Inpatients ; Interferon-gamma Release Tests/standards ; Latent Tuberculosis/diagnosis ; Male ; Middle Aged ; Mycobacterium tuberculosis/immunology ; Retrospective Studies ; Rhode Island ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: High mortality during tuberculosis retreatment at a Ghanaian tertiary center: a retrospective cohort study.
Autorzy:: Bouton TC; Division of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, Rhode Island.
Forson A; University of Ghana School of Medicine and Dentistry, Accra, Ghana.
Kudzawu S; Korle-Bu Teaching Hospital, Accra, Ghana.
Zigah F; Korle-Bu Teaching Hospital, Accra, Ghana.
Jenkins H; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Bamfo TD; Korle-Bu Teaching Hospital, Accra, Ghana.
Carter J; Division of Pulmonary, Critical Care and Sleep Medicine, Warren Alpert School of Medicine, Brown University, Providence, Rhode Island.
Jacobson K; Section of Infectious Diseases, Boston University School of Medicine, Boston, Massachusetts.
Kwara A; Division of Infectious Diseases & Global Medicine, University of Florida College of Medicine, Gainesville, Florida.; Pokaż więcej
Źródło:: The Pan African medical journal [Pan Afr Med J] 2019 Jun 13; Vol. 33, pp. 111. Date of Electronic Publication: 2019 Jun 13 (Print Publication: 2019).
Typ publikacji:: Journal Article
MeSH Terms:: Antitubercular Agents/*administration & dosage
Mycobacterium tuberculosis/*drug effects
Tuberculosis/*drug therapy
Tuberculosis, Multidrug-Resistant/*drug therapy
Adult ; Antitubercular Agents/pharmacology ; Cohort Studies ; Drug Resistance, Multiple, Bacterial ; Female ; Ghana ; HIV Infections/epidemiology ; Humans ; Isoniazid/pharmacology ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Multivariate Analysis ; Proportional Hazards Models ; Retreatment ; Retrospective Studies ; Rifampin/pharmacology ; Tuberculosis/microbiology ; Tuberculosis/mortality ; Tuberculosis, Multidrug-Resistant/microbiology ; Tuberculosis, Multidrug-Resistant/mortality

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol.
Autorzy:: Myers B; Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Bouton TC; Division of Infectious Diseases, Brown University Alpert School of Medicine, Providence, RI, USA.
Ragan EJ; Section of Infectious Diseases, Boston University School of Medicine, 801 Massachusetts Avenue, 2nd floor, Crosstown Center, Boston, MA, 02118, USA.
White LF; Department of Biostatistics Boston University School of Public Health, Boston, MA, USA.
McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Theron D; Brewelskloof Hospital, Worcester, South Africa.
Parry CDH; Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa.
Horsburgh CR; Department of Medicine, Boston University School of Medicine, Boston, MA, USA.; Departments of Epidemiology, Biostatistics and Global Health, Boston University School of Public Health, Boston, MA, USA.
Warren RM; Department of Science and Technology, National Research Foundation Centre of Excellence in Biomedical Tuberculosis Research, South Africa Medical Research Council for Molecular Biology and Human Genetics, Stellenbosch University, Tyberberg, South Africa.
Jacobson KR; Section of Infectious Diseases, Boston University School of Medicine, 801 Massachusetts Avenue, 2nd floor, Crosstown Center, Boston, MA, 02118, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2018 Sep 29; Vol. 18 (1), pp. 488. Date of Electronic Publication: 2018 Sep 29.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Alcohol Drinking*
Antitubercular Agents/*therapeutic use
Tuberculosis/*drug therapy
Adult ; Antitubercular Agents/metabolism ; Antitubercular Agents/pharmacokinetics ; Blood Cell Count ; Drug Resistance, Bacterial/drug effects ; Female ; Glycerophospholipids/analysis ; Half-Life ; Humans ; Longitudinal Studies ; Male ; Medication Adherence ; Middle Aged ; Mycobacterium tuberculosis/drug effects ; Mycobacterium tuberculosis/isolation & purification ; Proportional Hazards Models ; Prospective Studies ; Sputum/microbiology ; Treatment Outcome ; Tuberculosis/pathology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.
Autorzy:: Bouton TC; Brown University Alpert School of Medicine, Providence, RI, USA.
Phillips PPJ; Medical Research Council Clinical Trials Unit at University College London, London, UK.
Mitnick CD; Department of Global Health & Social Medicine, Harvard Medical School, Boston, MA, USA.
Peloquin CA; Infectious Disease Pharmacokinetics Lab, University of Florida, Gainesville, FL, USA.
Eisenach K; University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Patientia RF; Stellenbosch University and Task Applied Science, Cape Town, South Africa.
Lecca L; Socios en Salud Sucursal Peru, Lima, Peru.
Gotuzzo E; Universidad Peruana Cayetano Heredia, Lima, Peru.
Gandhi NR; Departments of Epidemiology, Global Health & Infectious Diseases, Rollins School of Public Health and Emory School of Medicine, Emory University, Atlanta, GA, USA.
Butler D; Westat, Bethesda, MA, USA.
Diacon AH; Stellenbosch University and Task Applied Science, Cape Town, South Africa.
Martel B; Socios en Salud Sucursal Peru, Lima, Peru.
Santillan J; Universidad Peruana Cayetano Heredia, Lima, Peru.
Hunt KR; Westat, Bethesda, MA, USA.
Vargas D; Socios en Salud Sucursal Peru, Lima, Peru.
von Groote-Bidlingmaier F; Stellenbosch University and Task Applied Science, Cape Town, South Africa.
Seas C; Universidad Peruana Cayetano Heredia, Lima, Peru.
Dianis N; Westat, Bethesda, MA, USA.
Moreno-Martinez A; TB Investigation Unit of Barcelona, Barcelona, Spain.; CIBER de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
Horsburgh CR Jr; Department of Medicine, Boston University School of Medicine, Boston, MA, USA. .; Departments of Epidemiology, Biostatistics and Global Health, Boston University School of Public Health, 715 Albany Street, T3E, Boston, MA, 02118, USA. .; Pokaż więcej
Źródło:: Trials [Trials] 2017 Nov 25; Vol. 18 (1), pp. 563. Date of Electronic Publication: 2017 Nov 25.
Typ publikacji:: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:: Drug Resistance, Multiple, Bacterial*
Antitubercular Agents/*administration & dosage
Levofloxacin/*administration & dosage
Mycobacterium tuberculosis/*drug effects
Tuberculosis, Multidrug-Resistant/*drug therapy
Tuberculosis, Pulmonary/*drug therapy
Antitubercular Agents/adverse effects ; Antitubercular Agents/pharmacokinetics ; Clinical Protocols ; Drug Administration Schedule ; Drug Therapy, Combination ; Humans ; Levofloxacin/adverse effects ; Levofloxacin/pharmacokinetics ; Microbial Sensitivity Tests ; Research Design ; Time Factors ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/diagnosis ; Tuberculosis, Multidrug-Resistant/microbiology ; Tuberculosis, Pulmonary/diagnosis ; Tuberculosis, Pulmonary/microbiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Bouton TC"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język